Free Trial
→ Do NOT Buy SpaceX – Do This Instead (From Stansberry Research) (Ad)tc pixel Free MOTS Stock Alerts

Motus GI (MOTS) Competitors

Motus GI logo
$0.0002 0.00 (0.00%)
As of 10/9/2026
Compare

MOTS vs. AFIB, UTRS, DRTSW, BDMDW, and COCHW

Should you buy Motus GI stock or one of its competitors? Motus GI's main competitors and comparable companies include Acutus Medical (AFIB), Minerva Surgical (UTRS), Alpha Tau Medical (DRTSW), Baird Medical Investment (BDMDW), and Envoy Medical (COCHW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Motus GI compare to Acutus Medical?

Motus GI (NASDAQ:MOTS) and Acutus Medical (NASDAQ:AFIB) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk.

Motus GI has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Motus GI's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Motus GIN/A N/A N/A
Acutus Medical -272.74%-311.64%-11.57%

In the previous week, Motus GI's average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score.

Company Overall Sentiment
Motus GI Neutral
Acutus Medical Neutral

Motus GI has a beta of 0.68, suggesting that its share price is 32% less volatile than the broader market. Comparatively, Acutus Medical has a beta of 5.71, suggesting that its share price is 471% more volatile than the broader market.

20.1% of Motus GI shares are owned by institutional investors. Comparatively, 56.9% of Acutus Medical shares are owned by institutional investors. 0.3% of Motus GI shares are owned by company insiders. Comparatively, 5.2% of Acutus Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Motus GI has higher earnings, but lower revenue than Acutus Medical. Acutus Medical is trading at a lower price-to-earnings ratio than Motus GI, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Motus GI$319K0.00-$12.87M-$14.69N/A
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A

Summary

Motus GI beats Acutus Medical on 6 of the 11 factors compared between the two stocks.

How does Motus GI compare to Minerva Surgical?

Motus GI (NASDAQ:MOTS) and Minerva Surgical (NASDAQ:UTRS) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation.

20.1% of Motus GI shares are held by institutional investors. 0.3% of Motus GI shares are held by insiders. Comparatively, 8.5% of Minerva Surgical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
Motus GIN/A N/A N/A
Minerva Surgical N/A N/A N/A

In the previous week, Motus GI's average media sentiment score of 0.00 equaled Minerva Surgical'saverage media sentiment score.

Company Overall Sentiment
Motus GI Neutral
Minerva Surgical Neutral

Motus GI has higher earnings, but lower revenue than Minerva Surgical. Motus GI is trading at a lower price-to-earnings ratio than Minerva Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Motus GI$319K0.00-$12.87M-$14.69N/A
Minerva Surgical$51.69M0.00-$34.11M-$1.81N/A

Motus GI has a beta of 0.68, suggesting that its stock price is 32% less volatile than the broader market. Comparatively, Minerva Surgical has a beta of 2.37, suggesting that its stock price is 137% more volatile than the broader market.

Summary

Minerva Surgical beats Motus GI on 4 of the 7 factors compared between the two stocks.

How does Motus GI compare to Alpha Tau Medical?

Motus GI (NASDAQ:MOTS) and Alpha Tau Medical (NASDAQ:DRTSW) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.

Company Net Margins Return on Equity Return on Assets
Motus GIN/A N/A N/A
Alpha Tau Medical N/A N/A N/A

Alpha Tau Medical has lower revenue, but higher earnings than Motus GI.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Motus GI$319K0.00-$12.87M-$14.69N/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

20.1% of Motus GI shares are held by institutional investors. 0.3% of Motus GI shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Alpha Tau Medical had 3 more articles in the media than Motus GI. MarketBeat recorded 3 mentions for Alpha Tau Medical and 0 mentions for Motus GI. Alpha Tau Medical's average media sentiment score of 0.27 beat Motus GI's score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the news media.

Company Overall Sentiment
Motus GI Neutral
Alpha Tau Medical Neutral

Summary

Motus GI beats Alpha Tau Medical on 3 of the 5 factors compared between the two stocks.

How does Motus GI compare to Baird Medical Investment?

Baird Medical Investment (NASDAQ:BDMDW) and Motus GI (NASDAQ:MOTS) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, valuation, media sentiment, profitability, risk, dividends, earnings and institutional ownership.

In the previous week, Baird Medical Investment had 1 more articles in the media than Motus GI. MarketBeat recorded 1 mentions for Baird Medical Investment and 0 mentions for Motus GI. Baird Medical Investment's average media sentiment score of 1.79 beat Motus GI's score of 0.00 indicating that Baird Medical Investment is being referred to more favorably in the media.

Company Overall Sentiment
Baird Medical Investment Very Positive
Motus GI Neutral

Baird Medical Investment has higher revenue and earnings than Motus GI.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Baird Medical Investment$24.49MN/AN/AN/AN/A
Motus GI$319K0.00-$12.87M-$14.69N/A

Company Net Margins Return on Equity Return on Assets
Baird Medical InvestmentN/A N/A N/A
Motus GI N/A N/A N/A

20.1% of Motus GI shares are owned by institutional investors. 0.3% of Motus GI shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Baird Medical Investment beats Motus GI on 3 of the 5 factors compared between the two stocks.

How does Motus GI compare to Envoy Medical?

Envoy Medical (NASDAQ:COCHW) and Motus GI (NASDAQ:MOTS) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, earnings and risk.

20.1% of Motus GI shares are held by institutional investors. 0.3% of Motus GI shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Envoy Medical had 2 more articles in the media than Motus GI. MarketBeat recorded 2 mentions for Envoy Medical and 0 mentions for Motus GI. Envoy Medical's average media sentiment score of 1.39 beat Motus GI's score of 0.00 indicating that Envoy Medical is being referred to more favorably in the media.

Company Overall Sentiment
Envoy Medical Positive
Motus GI Neutral

Envoy Medical has higher earnings, but lower revenue than Motus GI.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envoy Medical$207KN/AN/AN/AN/A
Motus GI$319K0.00-$12.87M-$14.69N/A

Company Net Margins Return on Equity Return on Assets
Envoy MedicalN/A N/A N/A
Motus GI N/A N/A N/A

Summary

Motus GI beats Envoy Medical on 3 of the 5 factors compared between the two stocks.

Get Motus GI News Delivered to You Automatically

Sign up to receive the latest news and ratings for MOTS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MOTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MOTS vs. The Competition

Export
MetricMotus GIHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$1K$5.51B$7.26B$13.29B
Dividend YieldN/A1.76%2.52%22.58%
P/E Ratio0.0025.57275.2826.14
Price / Sales0.0071.84586.2687.63
Price / CashN/A32.5627.3036.12
Price / Book0.005.9510.826.16
Net Income-$12.87M$146.14M$3.50B$381.12M
7 Day PerformanceN/A-0.28%-0.89%-1.40%
1 Month PerformanceN/A-2.08%-4.02%-3.35%
1 Year PerformanceN/A5.39%7.13%1.49%

Motus GI Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MOTS
Motus GI
N/A$0.00
flat		N/AN/A$1K$319KN/A15
AFIB
Acutus Medical
N/A$0.00
flat		N/A-95.0%$3K$7.16MN/A85
UTRS
Minerva Surgical
N/A$0.00
flat		N/AN/A$1K$51.69MN/A174
DRTSW
Alpha Tau Medical
N/A$4.09
-2.2%		N/A+997.8%$0.00N/AN/A121
BDMDW
Baird Medical Investment
N/A$0.03
flat		N/AN/A$0.00$24.49MN/A146

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:MOTS) was last updated on 10/11/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Here’s Why Trump Won’t End The Iran War
Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...
Banyan Hill Publishing | Sponsoredtc pixel